Drug Profile
Mecamylamine - Targacept
Alternative Names: Inversine; TRIDMACLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Merck & Co; Targacept
- Developer Targacept
- Class Eye disorder therapies; Norbornanes; Small molecules
- Mechanism of Action Nicotinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Market Withdrawal Hypertension
- Discontinued Attention-deficit hyperactivity disorder; Major depressive disorder
Most Recent Events
- 30 Sep 2009 Withdrawn for Hypertension in USA (PO)
- 30 Oct 2007 Discontinued - Phase-II for Depression in India (PO)
- 30 Oct 2007 Discontinued - Phase-II for Depression in USA (PO)